Wolverine has one particular ability that is wildly controversial in the X-Men fandom, & now, Marvel Comics has decided to ...
Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a ...
The FDA has approved two new biosimilars of denosumab-dssb to treat osteoporosis, increase bone mass, prevent ...
Learning you have a life-changing condition is likely alarming no matter what. But if you have axial spondyloarthritis (axSpA ...
The approval was based on a comprehensive clinical data package, which included a single phase 1 trial and a phase 3 trial.
Samsung Bioepis’ biosimilars Ospomyv and Xbryk have been approved to be interchangeable with Prolia/Xgeva treat osteoporosis and multiple myeloma/bone metastases from solid tumors.
T he sun is barely rising in rural Burundi when we begin our medical rounds in the pediatric ward. I am an American, ...
Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCE™, XBRYK™)
Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe ...
Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OSPOMYV™ (denosumab-dssb; SB16; 60 mg pre-filled ...
All That's Interesting on MSN3d
This Medieval Warrior Had His Hand Amputated, Then Replaced It With A Prosthetic KnifeArchaeologists have uncovered the skeleton of a warrior in northern Italy from the 6th century who after having his hand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback